Get the Stockscreener App
3.22
5.29%
-0.18
After Hours:
3.22
Sana Biotechnology Inc stock is traded at $3.22, with a volume of 3.00M.
It is down -5.29% in the last 24 hours and up +3.54% over the past month.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
See More
Previous Close:
$3.40
Open:
$3.4
24h Volume:
3.00M
Relative Volume:
0.55
Market Cap:
$765.74M
Revenue:
-
Net Income/Loss:
$-252.18M
P/E Ratio:
-3.0377
EPS:
-1.06
Net Cash Flow:
$-185.29M
1W Performance:
+8.78%
1M Performance:
+3.54%
6M Performance:
+10.27%
1Y Performance:
-28.92%
1-Day Range:
$3.18
$3.40
1-Week Range:
$2.865
$3.415
52-Week Range:
$1.26
$7.30
Sana Biotechnology Inc Stock (SANA) Company Profile
Name
Sana Biotechnology Inc
Sector
Industry
Phone
(206) 701-7914
Address
188 EAST BLAINE STREET, SUITE 400, SEATTLE
Compare SANA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
3.22 | 748.60M | 0 | -252.18M | -185.29M | -1.06 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-03-25 | Resumed | Morgan Stanley | Overweight |
| Mar-18-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Mar-14-25 | Initiated | Jefferies | Buy |
| Jan-08-25 | Upgrade | TD Cowen | Hold → Buy |
| Nov-05-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jun-26-24 | Initiated | Rodman & Renshaw | Buy |
| Jan-16-24 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Sep-25-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-05-23 | Initiated | Citigroup | Buy |
| Aug-14-23 | Initiated | TD Cowen | Market Perform |
| May-02-23 | Initiated | H.C. Wainwright | Neutral |
| Mar-01-21 | Initiated | BofA Securities | Buy |
| Mar-01-21 | Initiated | Goldman | Neutral |
| Mar-01-21 | Initiated | JP Morgan | Neutral |
| Mar-01-21 | Initiated | Morgan Stanley | Overweight |
View All
Sana Biotechnology Inc Stock (SANA) Latest News
Invesco Ltd. Buys 117,144 Shares of Sana Biotechnology, Inc. $SANA - MarketBeat
Ieq Capital LLC Raises Stock Holdings in Sana Biotechnology, Inc. $SANA - MarketBeat
Vident Advisory LLC Boosts Holdings in Sana Biotechnology, Inc. $SANA - Defense World
Sana Biotechnology, Inc. (NASDAQ:SANA) Given Average Rating of "Buy" by Brokerages - MarketBeat
Clearline Capital LP Purchases New Holdings in Sana Biotechnology, Inc. $SANA - MarketBeat
Rafferty Asset Management LLC Reduces Stock Position in Sana Biotechnology, Inc. $SANA - MarketBeat
Can Sana Biotechnology Inc. be the next market leaderQuarterly Investment Review & Safe Capital Growth Stock Tips - Lancaster City Council
Can CRISPR Finally Cure Type 1 Diabetes for Good? - Securities.io
Nuveen LLC Makes New Investment in Sana Biotechnology, Inc. $SANA - MarketBeat
Sana Biotechnology Inc. Outperforms Peers on Volume Metrics2025 Biggest Moves & Verified Short-Term Plans - beatles.ru
JMP Securities Keeps Market Outperform Rating on Sana Biotechnology (SANA) - Insider Monkey
Sana Biotechnology, Inc. $SANA Shares Acquired by Hsbc Holdings PLC - Defense World
SANA Gears Up to Report Q4 Earnings: What's in the Cards? - MSN
What is the long term forecast for Sana Biotechnology Inc. stockQuarterly Trade Review & Community Consensus Stock Picks - beatles.ru
Sana Biotechnology, Inc. $SANA Shares Sold by Baker BROS. Advisors LP - MarketBeat
Technical signs of recovery in Sana Biotechnology Inc.Earnings Recap Summary & Weekly High Return Stock Opportunities - Newser
Has Sana Biotechnology Inc. found a price floorJuly 2025 Spike Watch & Daily Chart Pattern Signal Reports - Newser
Sana Biotechnology Announces Leadership Transition - The Globe and Mail
Sana Reports Promising Diabetes Cell Therapy Data at ADA Meeting - MSN
Certain Common Stock of Sana Biotechnology, Inc. are subject to a Lock-Up Agreement Ending on 6-SEP-2025. - MarketScreener
Certain Stock Options of Sana Biotechnology, Inc. are subject to a Lock-Up Agreement Ending on 6-SEP-2025. - MarketScreener
Is Sana Biotechnology Inc.’s ROE strong enoughQuarterly Earnings Summary & Reliable Entry Point Trade Alerts - خودرو بانک
Is Sana Biotechnology Inc. exposed to political riskTrade Signal Summary & Weekly Momentum Picks - خودرو بانک
Does Sana Biotechnology Inc. fit your quant trading model2025 Fundamental Recap & Fast Gain Swing Trade Alerts - Newser
Sana Biotechnology shares rise 1.01% premarket after analyst presentations at Wells Fargo and Morgan Stanley conferences. - AInvest
How to build a custom watchlist for Sana Biotechnology Inc.July 2025 Spike Watch & Real-Time Volume Spike Alerts - Newser
What MACD and RSI say about Sana Biotechnology Inc.Quarterly Trade Summary & Verified Entry Point Signals - Newser
Combining machine learning predictions for Sana Biotechnology IncDividend Hike & Real-Time Stock Entry Alerts - Newser
Sana Biotechnology announces retirement of executive vice president and appointment of new chief legal officer - Investing.com
Sana Biotechnology Inc. stock chart pattern explainedWall Street Watch & Verified Momentum Stock Ideas - Newser
What’s Sana Biotechnology Inc.’s historical returnMarket Activity Summary & Safe Capital Growth Tips - خودرو بانک
What recovery options are there for Sana Biotechnology Inc.Weekly Trend Summary & Weekly High Return Stock Opportunities - Newser
Sana Biotechnology’s Position in the Engineered Cell Therapy Landscape - AInvest
Is Sana Biotechnology Inc. showing signs of accumulationGold Moves & Low Drawdown Momentum Trade Ideas - Newser
Market Outlook: Is Sana Biotechnology Inc.’s ROE strong enough2025 Market WrapUp & Safe Entry Trade Reports - خودرو بانک
Can a trend reversal in Sana Biotechnology Inc. lead to recoveryDip Buying & Free Fast Entry Momentum Trade Alerts - Newser
Combining machine learning predictions for Sana Biotechnology Inc.2025 Winners & Losers & Weekly Consistent Profit Watchlists - Newser
Using Python tools to backtest Sana Biotechnology Inc. strategiesWall Street Watch & Community Verified Swing Trade Signals - Newser
Is Sana Biotechnology Inc. reversing from oversold territoryWeekly Trade Recap & Precise Buy Zone Identification - Newser
What to expect from Sana Biotechnology Inc. in the next 30 days2025 Volatility Report & Weekly High Momentum Picks - Newser
Applying sector rotation models to Sana Biotechnology Inc.2025 Support & Resistance & Weekly Chart Analysis and Trade Guides - Newser
Multi factor analysis applied to Sana Biotechnology Inc.Market Activity Recap & Weekly Momentum Picks - Newser
Can volume confirm reversal in Sana Biotechnology Inc.July 2025 Catalysts & High Accuracy Swing Trade Signals - Newser
Building trade automation scripts for Sana Biotechnology Inc.Portfolio Growth Summary & Daily Technical Stock Forecast Reports - Newser
Real time social sentiment graph for Sana Biotechnology Inc.Weekly Stock Summary & Daily Technical Stock Forecast Reports - Newser
Sana Biotechnology shares rise 2.11% intraday after presenting at Citi's Biopharma Back. - AInvest
What the charts say about Sana Biotechnology Inc. todaySell Signal & AI Enhanced Trade Execution Alerts - Newser
Is it time to cut losses on Sana Biotechnology Inc.Analyst Downgrade & Weekly Top Gainers Alerts - Newser
Technical signs of recovery in Sana Biotechnology IncJuly 2025 PostEarnings & Verified Trade Idea Suggestions - Newser
Sana Biotechnology Inc Stock (SANA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):